CPAP for COPD and Sleep Apnea
(COPD Readmit Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if using CPAP (a machine that helps keep airways open during sleep) can prevent individuals with COPD (a lung disease that makes breathing difficult) and sleep apnea from needing to return to the hospital soon after discharge. Participants will receive either standard care or standard care plus CPAP therapy. Ideal candidates for this trial are those who have been hospitalized for COPD, experience sleep apnea, and have not used CPAP in the last six months. As an unphased trial, this study provides an opportunity to contribute to important research that could enhance future care for COPD and sleep apnea patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that CPAP therapy is safe for COPD and sleep apnea patients?
Research has shown that CPAP therapy, commonly used for sleep apnea, is generally safe for individuals with moderate to severe cases. Studies indicate that it can enhance quality of life by alleviating sleep apnea symptoms.
However, caution is advised for those with chronic obstructive pulmonary disease (COPD). Confirming safety is important, as there may be increased risks for these patients. While CPAP is widely used, discussing any concerns with a healthcare provider is crucial, especially for those with COPD.
Regular use of CPAP therapy has been linked to better outcomes, such as reduced daytime sleepiness and improved overall well-being. Many patients tolerate CPAP therapy well, but individual health conditions should be considered.12345Why are researchers excited about this trial?
Researchers are excited about CPAP therapy for COPD and sleep apnea because it offers a unique approach to managing these conditions. Unlike standard treatments that focus primarily on pharmacotherapy, CPAP therapy delivers continuous positive airway pressure to keep airways open during sleep, which can improve breathing and reduce sleep disruptions. This method is enhanced by wireless connectivity that monitors adherence, allowing for personalized adjustments and support. By combining CPAP with standard care, there is potential for better management of symptoms and reduced hospital readmissions, making it a promising option for patients with COPD and sleep apnea.
What evidence suggests that CPAP therapy might be an effective treatment for COPD and sleep apnea?
Research has shown that CPAP therapy, which participants in this trial may receive, can help individuals with COPD and sleep apnea. One study found that it led to fewer hospital visits for COPD and a lower risk of death. Another study demonstrated that CPAP reduced hospital admissions for those with both COPD and sleep apnea. CPAP provides a steady flow of air to keep airways open during sleep, easing breathing problems. Although some studies have mixed results, the overall evidence suggests that CPAP can make a significant difference.26789
Who Is on the Research Team?
Dennis Hwang, MD
Principal Investigator
Kaiser Permanente, Fontana Medical Center
Are You a Good Fit for This Trial?
This trial is for adults over 18 who are members of Kaiser Permanente, diagnosed with COPD and have OSA-predominant sleep disordered breathing. They must not have used CPAP recently, be non-sleepy (ESS below 11), speak English, and not require oxygen therapy or have other specific health exclusions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Diagnosis
Patients undergo a portable sleep study to diagnose OSA-predominant sleep disordered breathing
Treatment
Patients with OSA receive CPAP therapy in the hospital followed by home CPAP therapy
Follow-up
Participants are monitored for readmission rates, adherence to CPAP therapy, and presence of symptoms
What Are the Treatments Tested in This Trial?
Interventions
- CPAP Therapy
Trial Overview
The study aims to see if diagnosing OSA early and starting CPAP treatment in hospitalized COPD patients can lower the chances of them being readmitted within 30 days after discharge.
How Is the Trial Designed?
Patients will receive continuous positive airway pressure (CPAP) therapy in the hospital followed by home CPAP therapy. Their home CPAP therapy will include wireless connectivity, which includes adherence data. Furthermore, the patients will be entered into our usual automated platform (USleep; ResMed Corp) in which patients with suboptimal CPAP use will be sent messages (based on patient preference) in order to ensure adherence to therapy. This platform is already a standard part of our usual care. The patients will receive CPAP in addition to contemporary standard of care pharmacotherapy for their underlying COPD. They will follow up at the Fontana Sleep Center within 1 month after discharge for assessment of CPAP use and asked to complete a questionnaire packet. Patients will be followed during the 30-day period and assessed for readmission rates, time to readmission, adherence to CPAP therapy, and presence of symptoms.
Patients will receive contemporary standard of care pharmacotherapy for their underlying COPD condition and will not receive CPAP therapy for the duration of the study. They will be asked to follow up at the Fontana Sleep Center within 1 month after discharge for a repeat outpatient portable sleep study and asked to complete a questionnaire packet. The results of the outpatient portable sleep studies will be compared with the in-patient portable sleep study. Patients will also be asked to follow up with the Fontana Sleep Center within 1 month after discharge for assessment of primary and secondary outcomes. Patients will be followed during the 30-day period and assessed for readmission rates, time to readmission, adherence to CPAP therapy, and presence of symptoms.
CPAP Therapy is already approved in United States, Canada, European Union for the following indications:
- Obstructive Sleep Apnea
- Central Sleep Apnea
- Mixed Sleep Apnea
- Sleep-Related Breathing Disorders
- Obstructive Sleep Apnea
- Central Sleep Apnea
- Mixed Sleep Apnea
- Sleep-Related Breathing Disorders
- Obstructive Sleep Apnea
- Central Sleep Apnea
- Mixed Sleep Apnea
- Sleep-Related Breathing Disorders
Find a Clinic Near You
Who Is Running the Clinical Trial?
Kaiser Permanente
Lead Sponsor
Citations
Impact of Positive Airway Pressure Therapy Adherence on ...
One small study showed that treatment with positive airway pressure (PAP) in patients with overlap syndrome reduced chronic obstructive pulmonary disease– ...
The use of continuous positive airway pressure in COPD ...
Our findings revealed that CPAP therapy improved clinical outcomes, including COPD exacerbation, COPD related hospitalization, and mortality in patients with ...
Continuous positive airway pressure improves respiratory ...
For non-RF-complicated COPD, CPAP was shown to significantly improve patient survival, and risk of hospital admission in those who also had obstructive sleep ...
May continuous positive airway pressure (CPAP) treatment ...
CPAP treatment would reduce this risk by correcting the hypoxic burden and sleep fragmentation. However, randomized controlled trials failed to ...
Assessment of continuous positive airway pressure effect ...
The study's purpose was to investigate the effect of one-night continuous positive airway pressure treatment (CPAP treatment) on circadian clock genes.
IMPACT OF CONTINOUS POSITIVE AIRWAY PRESSURE ...
We found that long-term improvement in quality of life occurs with the use of CPAP in persons with severe and possibly moderate sleep apnea.
Treatment of Adult Obstructive Sleep Apnea With Positive ...
Overall, the analyses support the conclusion that CPAP is effective in reducing OSA severity as measured by the AHI or RDI, across the spectrum of OSA severity.
Continuous Positive Airway Pressure (CPAP) Therapy for ...
Use this page to view details for the decision Memo for Continuous Positive Airway Pressure (CPAP) Therapy for Obstructive Sleep Apnea (OSA) (CAG-00093R2).
Continuous Positive Airway Pressure Adherence Tracking ...
Increased CPAP adherence has been shown to improve outcomes such as daytime sleepiness, quality of life, and mortality (23–25). OSA should be considered in a ...
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.